PharmiWeb1d
Global Progressive Fibrosing Interstitial Lung Disease Market Projected to Reach USD 8654.1 Million by 2033 at a 6.2% of CAGR
The Progressive Fibrosing Interstitial Lung Disease (PF-ILD) market is currently valued at USD 4,742.2 Million in 2023 and is ...
The Impartial Reporter22h
Pulmonary fibrosis book draws global attention at ILD Conference
Enniskillen author and charity trustee Clare Donohoe recently addressed the Interstitial Lung Disease (ILD) Interdisciplinary Network conference ...
emjreviews.com2d
Antifibrotic Treatment Efficacy in Progressive Pulmonary Fibrosis: Single Centre Experience
In cases of pulmonary fibrosis attributable to interstitial lung disease, whether the aetiology is known or unknown, the ...
Pulmonary Fibrosis Foundation Appoints Dr. Amy Hajari Case as Chief Medical Officer
The Pulmonary Fibrosis Foundation (PFF), the nation's leading pulmonary fibrosis (PF) research, education and advocacy ...
Yahoo News UK1d
'Pete the Puffling’s Brave Adventure' draws global attention at ILD Conference
Enniskillen author and charity trustee Clare Donohoe recently addressed the Interstitial Lung Disease (ILD) Interdisciplinary ...
Medpage Today on MSN11d
CHEST Roundup: Diabetes in RA Patients Ups Risk of Interstitial Lung Disease
Moreover, diabetes was linked with a nearly fourfold increase in pulmonary fibrosis among patients with RA (OR 3.704, 95% CI ...
Too Old to Operate8d
Comparative Analysis of ILD in Patients With RA and PsA on Biologics
The following is a summary of “Interstitial Lung Disease in Patients With Rheumatoid Arthritis or Psoriatic Arthritis ...
The American Journal of Managed Care4d
Delayed Diagnoses, Oxygen Therapy Use Linked to Worse Outcomes in Patients With Fibrotic ILD
Posters presented at the CHEST 2024 annual meeting revealed that delays in diagnosing fibrotic interstitial lung disease (ILD ...
EurekAlert!8d
BU, Boston Medical Center researchers join forces with GSK to fight lung diseases
Researchers from the Center for Regenerative Medicine at Boston University and Boston Medical Center have announced a new collaboration with the global biopharma company GSK to advance innovative ...
News Medical on MSN7d
Boston University and GSK collaborate to tackle pulmonary fibrosis
Researchers from the Center for Regenerative Medicine (CReM) at Boston University and (BMC) have announced a new collaboration with the global biopharma company GSK to advance innovative research ...
American Lung Association Invests $22 Million in Lung Health Research
Today, the American Lung Association Research Institute announced a $22 million research investment in the past year, making ...
Butler Eagle6d
Couple claims delayed diagnosis led to irreversible end stage renal disease
A Center Township man and his wife have filed a lawsuit claiming a yearslong delay in diagnosing his kidney disease led to him developing irreversible end state renal disease. Chad and Michelle Kuzar ...